Core Laboratories (NYSE: CLB) reported Q1 EPS of $0.05, $0.11 worse than the analyst estimate of $0.16. Revenue for the quarter came in at $128 million versus the consensus estimate of $126.47 million.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.